Insiders Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Real-time Estimate Cboe BZX Other stock markets 01:19:02 10/05/2024 am IST			5-day change	1st Jan Change
1.325 ^USD	-5.36%		+1.54%	+6.45%

01:23pm	Earnings Flash (AKBA) AKEBIA THERAPEUTICS Reports Q1 Revenue $32.6M	MT
23/04	Averoa Seeks EU Approval for Chronic Kidney Disease Drug	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Akebia Therapeutics, Inc. Announces Management Changes, Effective March 22, 2024	16/03	CI
Akebia Therapeutics Names Nicholas Grund as Chief Commercial Officer	10/01	MT
Akebia Therapeutics Announces Appointment of Nicholas Grund as Chief Commercial Officer	09/01	CI
Akebia Therapeutics, Inc. Announces the Appointment of Richard C. Malabre as Chief Accounting Officer and Principal Accounting Officer	09/01	CI
Akebia Therapeutics, Inc. Announces Executive Changes	02/23/02	CI
Akebia Therapeutics Names Ellen Snow as Finance Chief	13/23/13	MT
Akebia Therapeutics, Inc. Announces Executive Changes	13/23/13	CI
Akebia Therapeutics, Inc. Announces Executive Changes	16/22/16	CI
Akebia Therapeutics, Inc. Appoints Ron Frieson to Its Nominating and Corporate Governance Committee	16/21/16	CI
Akebia Therapeutics, Inc. Appoints Ron Frieson to Board of Directors	01/21/01	CI
Immunic : Hires Patrick Walsh as Chief Business Officer	14/21/14	MT
Akebia Therapeutics, Inc. Announces Board Resignations	23/21/23	CI
Akebia Therapeutics Appoints LeAnne M. Zumwalt, Dialysis Industry Leader, to Board of Directors	18/21/18	CI
Akebia Therapeutics, Inc. Appoints Violetta Cotreau as Principal Accounting Officer	29/21/29	CI
Akebia Therapeutics Announces Executive Changes, Effective June 29, 2020	19/20/19	CI
Akebia Therapeutics, Inc. Announces Board Changes	07/20/07	CI
Akebia Therapeutics, Inc. Announces Resignation of Scott A. Canute as Class I Director	12/19/12	CI
Akebia Therapeutics, Inc. Announces Management Changes	09/19/09	CI
Akebia Therapeutics, Inc. Announces Board Changes	27/19/27	CI
Akebia Therapeutics, Inc. Announces Committee Appointments	20/18/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Akebia Therapeutics, Inc.

Equities

AKBA

US00972D1054

Insiders

Filters